It is known that in MSI pancreatic cancer the amount of CD8+ T-cells at the invasive front in addition to the expression level of PD-1 and PD-L1 is higher than in pancreatic cancer with intact mismatch repair system [30] (Figure 1). The gene discussed is CD8A; the disease is familial pancreatic carcinoma.